This Article  • Full text  • PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Citing articles on ISI (19)  • Contact me when this article is cited  Related Content  • Related articles  • Similar articles in JAMA  Topic Collections  • Bacterial Infections  • Infectious Diseases, Other  • Public Health, Other  • Drug Therapy, Other  • Infectious Diseases  • Alert me on articles by topic  Social Bookmarking   What's this?

It's Not Just for Hospitals

Elizabeth A. Bancroft, MD, SM

JAMA. 2007;298:1803-1804.

	Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

Methicillin-resistant Staphylococcus aureus (MRSA) is a well-known hospital pathogen. More than 10% of bloodstream infections in hospitals are due to MRSA, and patients with MRSA have worse outcomes than those with methicillin-sensitive S aureus.^1-2 In recent years, identification of MRSA in otherwise healthy individuals in the community (community-associated MRSA) has become increasingly common.

Health care–associated and community-associated MRSA have different clinical and molecular epidemiology. Health care–associated MRSA is associated with invasive disease, health care exposure, and multidrug resistance. Community-associated MRSA has been primarily reported in young, healthy individuals with no recent health care exposure. The strains have generally been sensitive to non–-lactam antibiotics, although most have had genes for the Panton-Valentine leukocidin and other enterotoxins that may make these strains more virulent.^3-5 Health care–associated MRSA is typified by a USA100 pulse-field electrophoretic pattern, while USA300 is the most commonly reported community-associated MRSA pattern . . . [Full Text of this Article]

Author Affiliation: Los Angeles County Department of Public Health, Los Angeles, California.

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati     What's this?

RELATED ARTICLES

Invasive Methicillin-Resistant Staphylococcus aureus Infections in the United States
, , , , , , , , , , , , , , , , and
JAMA. ;298():1763-1771.
FULL TEXT  

Emergence of a Multiresistant Serotype 19A Pneumococcal Strain Not Included in the 7-Valent Conjugate Vaccine as an Otopathogen in Children
and
JAMA. ;298():1772-1778.
FULL TEXT  

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

A competition-based assay for the screening of species-specific antibiotics
Granieri et al.
J Antimicrob Chemother 2009;64:62-68.
ABSTRACT | FULL TEXT  

ARDB--Antibiotic Resistance Genes Database
Liu and Pop
Nucleic Acids Res 2009;37:D443-D447.
ABSTRACT | FULL TEXT  

Staphylococcus aureus--Probing for Host Weakness?
Camargo and Gilmore
J. Bacteriol. 2008;190:2253-2256.
FULL TEXT  

A Cholesterol Biosynthesis Inhibitor Blocks Staphylococcus aureus Virulence
Liu et al.
Science 2008;319:1391-1394.
ABSTRACT | FULL TEXT  

Protecting Your Patients, Colleagues, Family, and Yourself From Infection: First Wash
Alspach
Crit Care Nurse 2008;28:7-12.
FULL TEXT  

Invasive MRSA Infections
JWatch Emergency Med. 2007;2007:2-2.
FULL TEXT  

Pneumococcal Otopathogen Not Vulnerable to Approved Antibiotics and Vaccine
JWatch Emergency Med. 2007;2007:3-3.
FULL TEXT  

MRSA in the U.S.
JWatch Infect. Diseases 2007;2007:2-2.
FULL TEXT  

New Worries About Multidrug-Resistant Bacteria
JWatch General 2007;2007:2-2.
FULL TEXT